Laffer Tengler Investments Exelixis, Inc. Transaction History

Laffer Tengler Investments

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$16.3 - $21.14 $179,022 - $232,180	-10,983 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$17.95 - $25.56 $57,996 - $82,584	-3,231 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$20.53 - $25.22 $13,262 - $16,292	646 Added 24.99%	3,231 $73 Million
Q4 2020 Feb 19, 2021	BUY	$18.39 - $24.8 $47,538 - $64,108	2,585 New	2,585 $51.9 Million

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Laffer Tengler Investments, based on Form 13F filings with the SEC.

Stay updated on Laffer Tengler Investments with notifications on news.